Get more from less

Purigen’s unique, electric-field driven technology enables high-yield extraction and purification of nucleic acids from a wide range of sample types. Our system is especially well-suited for cancer samples including: FFPE tissues, fine needle aspirates (FNAs) and liquid biopsies, as well as rare or low numbers of cells such as CTCs.


Purigen’s bench top system is exceptionally simple to load and operate. Hands-on time to load multiple samples into our fluidic chip is limited to 2-5 minutes. Our compact, automated system then extracts, purifies, and quantifies the nucleic acids from all samples in 15 to 60 minutes, depending on the application.

Integrated quantitation

During the Purigen extraction process, the concentration of the nucleic acids increases by up to 10,000-fold, making even small amounts of material readily detectable. We quantify the concentrated nucleic acids as they move through our chip, thereby delivering purified, quantified material without sacrificing any amount of the precious sample.

Platform solution

Purification and quantitation are only the beginning. Purigen’s benchtop device is a platform technology designed to accommodate new and expanded capabilities simply by purchasing new consumable kits (consisting of a fluidic chip and reagents). Examples of these capabilities include enrichment and inline quality control measurements.